These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8439390

  • 1. The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients.
    Tohgi H, Abe T, Takahashi S.
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):27-34. PubMed ID: 8439390
    [Abstract] [Full Text] [Related]

  • 2. Effect of a synthetic norepinephrine precursor, L-threo-3,4- dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patients.
    Tohgi H, Abe T, Takahashi S, Takahashi J, Ueno M, Nozaki Y.
    Neurosci Lett; 1990 Aug 14; 116(1-2):194-7. PubMed ID: 2259448
    [Abstract] [Full Text] [Related]

  • 3. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G, Holmes C, Sullivan P, Goldstein DS.
    Clin Auton Res; 2019 Feb 14; 29(1):113-117. PubMed ID: 30229336
    [Abstract] [Full Text] [Related]

  • 4. Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes.
    Tohgi H, Abe T, Takahashi S, Takahashi J, Nozaki Y, Ueno M, Kikuchi T.
    J Neural Transm Park Dis Dement Sect; 1993 Feb 14; 5(1):17-26. PubMed ID: 8094960
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M, Ogawa N, Ujike H.
    J Neurol Sci; 1986 Mar 14; 73(1):39-44. PubMed ID: 3084714
    [Abstract] [Full Text] [Related]

  • 7. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
    Ogawa N, Yamamoto M, Takayama H.
    J Med; 1985 Mar 14; 16(5-6):525-34. PubMed ID: 3938472
    [Abstract] [Full Text] [Related]

  • 8. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
    Ishikawa Y, Kato Y, Murakami Y, Inoue T, Koshiyama H, Imura H.
    Proc Soc Exp Biol Med; 1987 Feb 14; 184(2):197-200. PubMed ID: 3101067
    [Abstract] [Full Text] [Related]

  • 9. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
    Eldrup E, Mogensen P, Jacobsen J, Pakkenberg H, Christensen NJ.
    Acta Neurol Scand; 1995 Aug 14; 92(2):116-21. PubMed ID: 7484057
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W, Naoi M, Narabayashi H.
    J Neurol Sci; 1996 Jul 14; 139(1):141-8. PubMed ID: 8836986
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. L-threo-3,4-dihydroxyphenylserine treatment for gait apraxia in parkinsonian patients.
    Yoshida M, Noguchi S, Kuramoto S.
    Kurume Med J; 1989 Jul 14; 36(2):67-74. PubMed ID: 2511378
    [Abstract] [Full Text] [Related]

  • 14. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A, Jackson-Lewis V, Fahn S.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov 14; 331(2-3):202-8. PubMed ID: 3937060
    [Abstract] [Full Text] [Related]

  • 15. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T, Sakoda S, Ueji M, Kishimoto S, Hayashi A, Kondo T, Narabayashi H.
    Neurology; 1984 Nov 14; 34(11):1446-50. PubMed ID: 6436731
    [Abstract] [Full Text] [Related]

  • 16. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain.
    Nishino N, Fujii Y, Kondo M, Shuntoh H, Fujiwara H, Tanaka C.
    J Pharmacol Exp Ther; 1987 Aug 14; 242(2):621-8. PubMed ID: 3112367
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J, Takahashi R.
    Psychiatry Res; 1985 Aug 14; 15(4):319-26. PubMed ID: 3934694
    [Abstract] [Full Text] [Related]

  • 20. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J, Constantinidis J, Puig M, Tissot R, Pletscher A.
    J Pharmacol Exp Ther; 1975 May 14; 193(2):523-32. PubMed ID: 1142103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.